All data are based on the daily closing price as of August 25, 2025
a

ASKA Pharmaceutical Holdings

4886.TSE
16.88 USD
-0.21
-1.23%

Overview

Last close
16.88 usd
Market cap
478.80M usd
52 week high
17.42 usd
52 week low
11.96 usd
Target price
17.32 usd

Valuation

P/E
13.852
Forward P/E
N/A
Price/Sales
1.0528
Price/Book Value
1.1009
Enterprise Value
533.57M usd
EV/Revenue
1.2251
EV/EBITDA
9.2555

Key financials

Revenue TTM
455.68M usd
Gross Profit TTM
215.89M usd
EBITDA TTM
48.87M usd
Earnings per Share
1.22 usd
Dividend
0.37 usd
Total assets
674.32M usd
Net debt
2.01M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. It operates through three segments: The Pharmaceutical Business, The Animal Health Business, and The Overseas Business. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers quasi-drugs, food supplements, and medical devices. In addition, the company manufactures and sells ethical pharmaceutical overseas. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top